alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1328 Glyceryl behenate. ( a ) Glyceryl behenate is a mixture of glyceryl esters of behenic acid made from glycerin and behenic acid (a saturated C22 fatty acid). The mixture contains predominately glyceryl dibehenate.
( b ) The ingredient meets the following specifications: ( 1 ) 10 to 20 percent monoglyceride, 47 to 59 percent diglyceride, 26 to 38 percent triglyceride, and not more than 2.5 percent free fatty acids.
( 2 ) *Behenic acid.* Between 80 and 90 percent of the total fatty acid content.
( 3 ) *Acid value.* Not more than 4.
( 4 ) *Saponification value.* Between 145 and 165.
( 5 ) *Iodine number.* Not more than 3.
( 6 ) *Heavy metals (as Pb).* Not more than 10 parts per million.
( c ) In accordance with § 184.1(b)(1) of this chapter, the ingredient is used in food with no limitation other than current good manufacturing practice. The affirmation of this ingredient is generally recognized as safe (GRAS) as a direct human food ingredient is based upon the following current good manufacturing practice conditions of use: ( 1 ) The ingredient is used as a formulation aid, as defined in § 170.3(o)(14) of this chapter.
( 2 ) The ingredient is used in excipient formulations for use in tablets at levels not to exceed good manufacturing practice.
[52 FR 42430, Nov. 5, 1987]
<TABLE> <S> <C>


<ARTICLE>                     5
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   YEAR                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1996             SEP-30-1995
<PERIOD-END>                               SEP-30-1996             SEP-30-1995
<CASH>                                       3,476,165               3,274,993
<SECURITIES>                                         0                       0
<RECEIVABLES>                                2,799,337                  79,069
<ALLOWANCES>                                         0                       0
<INVENTORY>                                  1,830,241                 691,001
<CURRENT-ASSETS>                            12,101,703               6,158,067
<PP&E>                                      37,926,880              33,283,135
<DEPRECIATION>                               1,779,445                 197,926
<TOTAL-ASSETS>                              53,284,805              44,097,276
<CURRENT-LIABILITIES>                       14,933,361               7,077,846
<BONDS>                                     21,962,060              24,500,000
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                     10,070                  10,000
<COMMON>                                        55,819                  49,319
<OTHER-SE>                                  16,130,477              12,460,111
<TOTAL-LIABILITY-AND-EQUITY>                53,284,805              44,097,276
<SALES>                                              0                       0
<TOTAL-REVENUES>                            47,816,881               7,255,830
<CGS>                                                0                       0
<TOTAL-COSTS>                               44,341,529               6,803,041
<OTHER-EXPENSES>                           (1,465,867)               (132,795)
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              2,009,485                 319,994
<INCOME-TAX>                                         0                   8,459
<INCOME-CONTINUING>                          2,009,485                 311,535
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 2,009,485                 311,535
<EPS-PRIMARY>                                     0.34                    0.06
<EPS-DILUTED>                                     0.34                    0.06
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          19,058
<INT-BEARING-DEPOSITS>                           9,656
<FED-FUNDS-SOLD>                                 5,210
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                     65,458
<INVESTMENTS-CARRYING>                           1,312
<INVESTMENTS-MARKET>                             1,332
<LOANS>                                        229,348
<ALLOWANCE>                                      2,613
<TOTAL-ASSETS>                                 350,479
<DEPOSITS>                                     307,586
<SHORT-TERM>                                         0
<LIABILITIES-OTHER>                              2,815
<LONG-TERM>                                      6,989
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        28,383
<OTHER-SE>                                       4,706
<TOTAL-LIABILITIES-AND-EQUITY>                 350,479
<INTEREST-LOAN>                                 21,501
<INTEREST-INVEST>                                2,065
<INTEREST-OTHER>                                 1,109
<INTEREST-TOTAL>                                24,675
<INTEREST-DEPOSIT>                               9,463
<INTEREST-EXPENSE>                               9,895
<INTEREST-INCOME-NET>                           14,780
<LOAN-LOSSES>                                      752
<SECURITIES-GAINS>                                (21)
<EXPENSE-OTHER>                                 10,628
<INCOME-PRETAX>                                  7,117
<INCOME-PRE-EXTRAORDINARY>                       7,117
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,864
<EPS-PRIMARY>                                     1.20
<EPS-DILUTED>                                     1.19
<YIELD-ACTUAL>                                    6.06
<LOANS-NON>                                      2,181
<LOANS-PAST>                                       764
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                 2,034
<CHARGE-OFFS>                                      990
<RECOVERIES>                                       117
<ALLOWANCE-CLOSE>                                2,613
<ALLOWANCE-DOMESTIC>                             2,613
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0
        

</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000945821
<NAME> CAPSTAR RADIO BROADCASTING PARTNERS, INC.
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          70,719
<SECURITIES>                                         0
<RECEIVABLES>                                   43,239
<ALLOWANCES>                                     2,889
<INVENTORY>                                          0
<CURRENT-ASSETS>                               114,768
<PP&E>                                         105,716
<DEPRECIATION>                                  10,211
<TOTAL-ASSETS>                               1,096,872
<CURRENT-LIABILITIES>                           30,552
<BONDS>                                        426,192
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         4,759
<OTHER-SE>                                     456,556
<TOTAL-LIABILITY-AND-EQUITY>                 1,096,872
<SALES>                                              0
<TOTAL-REVENUES>                               175,445
<CGS>                                                0
<TOTAL-COSTS>                                  120,091
<OTHER-EXPENSES>                                51,081
<LOSS-PROVISION>                                 2,044
<INTEREST-EXPENSE>                              30,559
<INCOME-PRETAX>                               (30,514)
<INCOME-TAX>                                   (4,910)
<INCOME-CONTINUING>                           (25,604)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                (2,403)
<CHANGES>                                            0
<NET-INCOME>                                  (28,007)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               JUN-30-1999
<CASH>                                          92,542
<SECURITIES>                                    19,741
<RECEIVABLES>                                3,217,459
<ALLOWANCES>                                    24,000
<INVENTORY>                                  1,955,231
<CURRENT-ASSETS>                             5,382,670
<PP&E>                                      17,277,859
<DEPRECIATION>                               3,963,659
<TOTAL-ASSETS>                              18,905,662
<CURRENT-LIABILITIES>                        3,527,095
<BONDS>                                      3,923,300
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     4,666,138
<OTHER-SE>                                   6,204,610
<TOTAL-LIABILITY-AND-EQUITY>                18,905,662
<SALES>                                      4,773,677
<TOTAL-REVENUES>                             6,058,968
<CGS>                                        5,003,808
<TOTAL-COSTS>                                  633,288
<OTHER-EXPENSES>                                 4,484
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              48,392
<INCOME-PRETAX>                                364,531
<INCOME-TAX>                                   146,000
<INCOME-CONTINUING>                            218,531
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   218,531
<EPS-BASIC>                                        .07
<EPS-DILUTED>                                      .07


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
COMPANY'S CONSOLIDATED FINANCIAL STATEMENTS INCLUDED IN FORM 10-Q AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JUN-30-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                      10,128,000
<SECURITIES>                                         0
<RECEIVABLES>                                3,801,000
<ALLOWANCES>                                 (167,000)
<INVENTORY>                                  5,273,000
<CURRENT-ASSETS>                            19,186,000
<PP&E>                                       3,195,000
<DEPRECIATION>                               1,849,000
<TOTAL-ASSETS>                              21,052,000
<CURRENT-LIABILITIES>                        2,584,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  4,948,000
<COMMON>                                    19,327,000
<OTHER-SE>                                 (5,807,000)
<TOTAL-LIABILITY-AND-EQUITY>                21,052,000
<SALES>                                     14,953,000
<TOTAL-REVENUES>                            14,953,000
<CGS>                                        6,875,000
<TOTAL-COSTS>                                6,810,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           (238,000)
<INCOME-PRETAX>                              1,506,000
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          1,506,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 1,506,000
<EPS-PRIMARY>                                      .18
<EPS-DILUTED>                                      .17
        

</TABLE>
§ 336.1 Scope. ( a ) An over-the-counter antiemetic drug product in a form suitable for oral administration is generally recognized as safe and effective and is not misbranded if it meets each of the conditions in this part and each of the general conditions established in § 330.1.
( b ) References in this part to regulatory sections of the Code of Federal Regulations are to chapter I of title 21 unless otherwise noted.
§ 182.6810 Sodium tripolyphosphate. ( a ) *Product.* Sodium tripolyphosphate.
( b ) *Conditions of use.* This substance is generally recognized as safe when used in accordance with good manufacturing practice.
Editorial Note on Part 184
Editorial Note: Nomenclature changes to part 184 appear at 66 FR 56035, Nov. 6, 2001; 66 FR 66742, Dec. 27, 2001; 68 FR 15355, Mar. 31, 2003; 69 FR 13717, Mar. 24, 2004; 70 FR 40880, July 15, 2005; 70 FR 67651, Nov. 8, 2005; and 81 FR 49897, July 29, 2016.

§ 184.1890 α-Tocopherols. ( a ) The α-tocopherols that are the subject of this GRAS affirmation regulation are limited to the following: ( 1 ) *d* -α-Tocopherol (CAS Reg. No. 59-02-9) is the chemical [2R,4′R,8′R]-2,5,7,8-tetramethyl-2-(4′,8′,12′-trimethyl-tridecyl)-6-chromanol. It occurs commercially as a concentrate and is a red, nearly odorless, viscous oil. It is obtained by vacuum steam distillation of edible vegetable oil products.
( 2 ) *dl* -α-Tocopherol (CAS Reg. No. 10191-41-0) is a mixture of stereoisomers of 2,5,7,8-tetramethyl-2-(4′,8′,12′-trimethyl-tridecyl)-6-chromanol. It is chemically synthesized by condensing racemic isophytol with trimethyl hydroquinone. It is a pale yellow viscous oil at room temperature.
( b ) The ingredients meet the specifications of the Food Chemicals Codex, 3d Ed. (1981), pp. 330-331, which is incorporated by reference. Copies are available from the National Academy Press, 2101 Constitution Ave. NW., Washington, DC 20418, or available for inspection at the National Archives and Records Administration (NARA). For information on the availability of this material at NARA, call 202-741-6030, or go to: *http://www.archives.gov/federal_register/code_of_federal_regulations/ibr_locations.html .*
( c ) In accordance with § 184.1(b)(3), the affirmation of the ingredients as generally recognized as safe is limited to the following conditions of use while the agency concludes the general evaluation of all food uses of tocopherols: ( 1 ) The ingredients are used as inhibitors of nitrosamine formation.
( 2 ) The ingredients are used in pump-cured bacon at levels not to exceed current good manufacturing practice.
[49 FR 13348, Apr. 4, 1984]
June 1, 1951 

Hon. Gordon L. Hollon 

County Attorney 

Kendall county 

Boerne, Texas 

Dear sir: 

Opinion No. V-1177. 

Re: Compensation of a county judge 

on a fee basis who is also ex 

officio county superintendent. 

Your request for an opinion presents the following two 

questions: 

1. Does the law require the compensation received 

by a county judge as ex officio county school superintendent to be included in the annual report as a portion 

of the maximum fees to be retained by him? 

2. Is the county juage'required to report compensation received as ex officio county superintendent adi 

expenses collected by him fop travel? 

Kendall County compensates its ccUnt,y officers on a fee 

basis. 

'It has been codstently held in prior opinions of this 

office that the compensation received as ex officio county superintendent by a county judge compensated on a fee basis must be inelu&zd in computfng his maximum compensation, and the county judge 

is not eptitled to compensation as ex officio county superintendent 

over and above his maximum allowed. The coudy judge must account 

for said ex officio compensation in arriving at hM maximum. Att'y 

&no ops, o-67 (igjg), o-263 (igjg), o-iglg (lg4,o), 0-3026 (194x), 

O-5251 <:1943), o-6365 (194, o-6749 (@+5). 

It has been likewise held that the traveling expense allowed the county judge as ex officio county superintendent should 

be shown on his monthly report as required by Article 3899, V.C+S. 

Att'y Gen. Op. O-l.277 (1939). 

You are therefore in ani3wer to your first question advised that the compensstti alloWe& the county judge as ex officio 

county s?~perintendent ists be included In computtig his maximum 

eDmpensat%on allowed by law, 
Hon. Gordon L. Hollon, page 2 (V-1177) 

You are advised in answer to your second question that the 

county judge must Include in his report, as required by Article 3899, 

the compensation and traveling expense he has received as ex officio 

county superintendent. 

SUMMARY 

Compens.+d.on received as ex officio county superintendent by a county judge compensated on a fee basis must 

be included in computing his maximum compensation, and 

the county judge is not entitled to compensation as ex 

officio county superintendent over and above his maximum 

allowed by law. The county judge must include in his report, as required by Article 3699, the compensation and 

traveling expense he has received as ex officio county 

superintendent. Att'y Gen. Ops. o-67 (19X3), 0-263 (1939), 

O-1919 (l&O), 0-3026 (19&l), O-5251 (1943), O-6365 (1945), 

o-6749 (1945). 

APPROVED: 

J. C. Davis, Jr. 

County Affairs Division 

Jesse P. Luton, Jr. 

Reviewing Assistant 

Charles D. Mathews 

First Assistant 

JR:mw:pwb 

Yours very truly, 

PRICE DANIEL 

Attorney General
<PAGE>   1


                                  EXHIBIT 24.2

                                POWER OF ATTORNEY
                                ROBERT T. KNIGHT


       KNOWN ALL MEN BY THESE PRESENTS, that the undersigned, Robert T. Knight,
hereby constitutes and appoints Gordon A. Gardiner or Mark D. Brown his true and
lawful attorney-in-fact and agent, for him and his name, place and stead, in any
and all capacities, to sign the Form 10-KSB of Data Dimensions, Inc., a Delaware
corporation, for the fiscal year ended December 31, 1997, and any amendments or
supplements thereto, and to file this Power of Attorney and the Form 10-KSB,
with all exhibits thereto, and other documents in connection therewith, with the
Securities and Exchange Commission and the NASDAQ National Market System,
granting unto said attorney-in-fact and agent full power and authority to do and
perform each requisite and necessary to be done in and about the premises, as
fully to all intents and purposes as he might or could do in person, hereby
ratifying and confirming all that said attorney-in-fact and agent, may do or
cause to be done by virtue hereof.

        Dated this 18th day of March, 1998.


Signature:



/s/  ROBERT T. KNIGHT
-------------------------------------
Robert T. Knight
EPA-SwRI Update (11-15-15)

• Testing Plan for Alternative Approach at SwRI

– Cummins ISB 300hp rating (24 points) - completed

– Cummins ISB 200hp rating (24 points)

– Navistar N13 455hp rating (27 points) - completed

– N13 engine with 365hp rating (27 points) - not started yet

– Ford 6.8 liter gasoline engine - not started yet

DRAFT & DELIBERATIVE 1
Mapping Points for ARB Cycle for ISB 

DRAFT & DELIBERATIVE 2

3.0

3.5

4.0

4.5

5.0

65 67 69 71 73 75 77 79 81 83 85

kW-hr

SN/SV

Interp/Extrap Points (Test Cell Data) Map Points (Test Cell Data)

• Use 300hp rating map to predict 200hp rating

• Green Points – 300hp rating

• Red points – 200hp rating
Numerical Approaches

• Triangulation (EPA’s interpolation/extrapolation)

• Model 1

– Global regression as function of N/V and N/V*W

• Model 3a

– Global linear regression as function of N/V and W

• Model 3b

– Global regression as function of N/V and W

– Regression model based on "hundreds" of GEM results

• Note:

– We totally abandoned strong nonlinear global regression as function of N/V, 

N/V^2 and N/V*W

DRAFT & DELIBERATIVE 3
Results with four methods (ARB)

DRAFT & DELIBERATIVE

4

240

250

260

270

280

290

300

310

320

240 250 260 270 280 290 300 310 320 Predicted BSFC [g/kWh]

Test Cell BSFC [g/kWh]

Triangulation ARB

Global Regression Model 1

Global Regression Model 3a

Global Regression Model 3b

ARB Cycle

MD - Cummins ISB - 200 hp
Next Steps

• N13 engine Child rating evaluation with 365hp rating 

(27 points)

• Finalize numerical schemes

DRAFT & DELIBERATIVE 5
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                  1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              DEC-30-2000
<PERIOD-START>                                 JAN-02-2000
<PERIOD-END>                                   JUL-01-2000
<CASH>                                              17,700
<SECURITIES>                                             0
<RECEIVABLES>                                       50,100
<ALLOWANCES>                                         2,400
<INVENTORY>                                        401,000
<CURRENT-ASSETS>                                   500,000
<PP&E>                                             367,900
<DEPRECIATION>                                     130,200
<TOTAL-ASSETS>                                     793,200
<CURRENT-LIABILITIES>                              409,700
<BONDS>                                                  0
<PREFERRED-MANDATORY>                                    0
<PREFERRED>                                              0
<COMMON>                                               300
<OTHER-SE>                                         271,300
<TOTAL-LIABILITY-AND-EQUITY>                       793,200
<SALES>                                          1,029,100
<TOTAL-REVENUES>                                 1,029,100
<CGS>                                              710,100
<TOTAL-COSTS>                                      710,100
<OTHER-EXPENSES>                                   257,800
<LOSS-PROVISION>                                         0
<INTEREST-EXPENSE>                                   3,100
<INCOME-PRETAX>                                     58,100
<INCOME-TAX>                                        18,200
<INCOME-CONTINUING>                                 18,200
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                        18,200
<EPS-BASIC>                                           0.91
<EPS-DILUTED>                                         0.89


</TABLE>